{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:43:30Z","timestamp":1792748610810,"version":"4.5.0"},"reference-count":67,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As dual modulators of Cannabinoid subtype 2 receptor (CB2R) and fatty acid amide hydrolase (FAAH)\ue5f8an arising therapeutic strategy against diseases based on neuroinflammation\ue5f8we developed a new series of N-adamantyl-benzamides bearing an anthranilic or salicylic scaffold. Derivatives 18, 22, and 25 emerged as an interesting compromise in terms of CB2R activity, CB2R\/CB1R selectivity, and FAAH inhibition. All compounds were potent FAAH inhibitors; 18 and 25 acted as unbiased CB2R agonists with no CB1R affinity, whereas 22 was a CB2R antagonist in the cAMP pathway and partial agonist in \u03b2-arrestin-2 recruitment. The three compounds were tested in monocytes and macrophages in resting and activated states and in a human activated microglia model with a potent anti-inflammatory action. These results support the CB2R and FAAH engagement as a promising dual strategy against neuroinflammation providing valuable chemical tools for probing the structural determinants underlying CB2R binding, long residence time, and biased signaling.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c02401","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:02:44Z","timestamp":1791388964000},"page":"24727-24747","source":"Crossref","is-referenced-by-count":0,"title":["Design and Development of New Dual Target Agents, Cannabinoid Subtype 2 Receptor (CB2R) Agonists, and Fatty Acid Amide Hydrolase (FAAH) Inhibitors against Neurodegeneration"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-3240","authenticated-orcid":true,"given":"Giovanni","family":"Graziano","sequence":"first","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mastropasqua","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Fanizzi","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6072-3388","authenticated-orcid":true,"given":"M. Giovanna E.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"National Research Council of Italy , , ,","place":["Bari, Italy, 70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-6155","authenticated-orcid":true,"given":"Antonio","family":"Laghezza","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6283-7312","authenticated-orcid":true,"given":"Mariachiara","family":"Mammone","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella Rosanna","family":"Musillo","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-2841","authenticated-orcid":true,"given":"Giuseppe Felice","family":"Mangiatordi","sequence":"additional","affiliation":[{"name":"National Research Council of Italy , , ,","place":["Bari, Italy, 70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1979","authenticated-orcid":true,"given":"Jose","family":"Brea","sequence":"additional","affiliation":[{"name":"University of Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]},{"name":"University of Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-0863","authenticated-orcid":true,"given":"Maria Isabel","family":"Loza","sequence":"additional","affiliation":[{"name":"University of Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]},{"name":"University of Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cas","family":"van der Horst","sequence":"additional","affiliation":[{"name":"Leiden University , , ,","place":["Leiden, The Netherlands, 2311"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-4836","authenticated-orcid":true,"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[{"name":"University of Torino , , ,","place":["Torino, Italy, 10126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Esposito","sequence":"additional","affiliation":[{"name":"National Research Council of Italy , , ,","place":["Pozzuoli (Napoli), Italy, 80078"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-5228","authenticated-orcid":true,"given":"Maria Grazia","family":"Perrone","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Leonetti","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-8464","authenticated-orcid":true,"given":"Laura H.","family":"Heitman","sequence":"additional","affiliation":[{"name":"Leiden University , , ,","place":["Leiden, The Netherlands, 2311"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5639-7746","authenticated-orcid":true,"given":"Nicola Antonio","family":"Colabufo","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-7972","authenticated-orcid":true,"given":"Angela","family":"Stefanachi","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-884X","authenticated-orcid":true,"given":"Carmen","family":"Abate","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ligresti","sequence":"additional","affiliation":[{"name":"National Research Council of Italy , , ,","place":["Pozzuoli (Napoli), Italy, 80078"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-3151","authenticated-orcid":true,"given":"Marialessandra","family":"Contino","sequence":"additional","affiliation":[{"name":"University of Bari ALDO MORO , , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"1","key":"2026102305085830500_cit1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri3362","article-title":"The Resolution of Inflammation","volume":"13","author":"Buckley","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"2026102305085830500_cit2","doi-asserted-by":"publisher","first-page":"115109","DOI":"10.1016\/j.ejmech.2023.115109","article-title":"N-Adamantyl-Anthranil Amide Derivatives: New Selective Ligands for the Cannabinoid Receptor Subtype 2 (CB2R)","volume":"248","author":"Graziano","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026102305085830500_cit3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/acs.jmedchem.2c01084","article-title":"Development of N-(1-Adamantyl)Benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase","volume":"66","author":"Intranuovo","year":"2023","journal-title":"J. Med. Chem."},{"issue":"6284","key":"2026102305085830500_cit4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a Cannabinoid Receptor and Functional Expression of the Cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"9","key":"2026102305085830500_cit5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The Endocannabinoid System and Its Therapeutic Exploitation","volume":"3","author":"Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"2026102305085830500_cit6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11892-019-1248-9","article-title":"The Expanded Endocannabinoid System\/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus","volume":"19","author":"Veilleux","year":"2019","journal-title":"Curr. Diab. Rep."},{"issue":"3","key":"2026102305085830500_cit7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2020.22.3\/vdimarzo","article-title":"The Endocannabinoidome as a Substrate for Noneuphoric Phytocannabinoid Action and Gut Microbiome Dysfunction in Neuropsychiatric Disorders","volume":"22","author":"Di Marzo","year":"2020","journal-title":"Dialogues Clin. Neurosci"},{"issue":"6","key":"2026102305085830500_cit8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids Mediate Neuron-Astrocyte Communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"2026102305085830500_cit9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"2026102305085830500_cit10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in Neurodegenerative Disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"2026102305085830500_cit11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 Receptors in the Brain: Role in Central Immune Function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"2026102305085830500_cit12","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409000957","article-title":"Emerging Role of the Cannabinoid Receptor CB2 in Immune Regulation: Therapeutic Prospects for Neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"2026102305085830500_cit13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1192\/bjp.178.2.101","article-title":"Pharmacology and Effects of Cannabis: A Brief Review","volume":"178","author":"Ashton","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"2026102305085830500_cit14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology","volume":"11","author":"Tanaka","year":"2020","journal-title":"Front. Neurol."},{"issue":"21","key":"2026102305085830500_cit15","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.3390\/molecules26216679","article-title":"Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy","volume":"26","author":"Wang","year":"2021","journal-title":"Molecules"},{"key":"2026102305085830500_cit16","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s10787-023-01259-0","article-title":"Neuromodulation in Parkinson\u2019s Disease Targeting Opioid and Cannabinoid Receptors, Understanding the Role of NLRP3 Pathway: A Novel Therapeutic Approach","volume":"31","author":"Alam","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"6","key":"2026102305085830500_cit17","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/ijms22062880","article-title":"Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet","volume":"22","author":"Gigante","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"2026102305085830500_cit18","doi-asserted-by":"publisher","first-page":"13538","DOI":"10.1002\/cam4.6037","article-title":"Overexpression of Cannabinoid Receptor 2 Is Associated with Human Breast Cancer Proliferation, Apoptosis, Chemosensitivity and Prognosis via the PI3K\/Akt\/mTOR Signaling Pathway","volume":"12","author":"Song","year":"2023","journal-title":"Cancer Med."},{"key":"2026102305085830500_cit19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnins.2017.00196","article-title":"Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation","volume":"11","author":"Contino","year":"2017","journal-title":"Front. Neurosci."},{"key":"2026102305085830500_cit20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-80962-1_368-1","article-title":"The Role of Cannabinoid Receptors Subtype 2 in Cancer","volume-title":"Handbook of Cancer and Immunology","author":"Fanizzi","year":"2025"},{"issue":"1","key":"2026102305085830500_cit21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13046-025-03476-7","article-title":"CC48 a New CB2R Agonist\/FAAH Inhibitor Dual Drug Blocks Gastric Cancer Progression and Overcomes Paclitaxel Resistance","volume":"44","author":"Schirizzi","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2026102305085830500_cit22","doi-asserted-by":"publisher","first-page":"105607","DOI":"10.1016\/j.phrs.2021.105607","article-title":"Medicinal Chemistry Approach, Pharmacology and Neuroprotective Benefits of CB2R Modulators in Neurodegenerative Diseases","volume":"170","author":"Ferrisi","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"24","key":"2026102305085830500_cit23","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.1021\/acs.jmedchem.7b00155","article-title":"Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure\u2212Affinity Relationship (SAfiR) and Structure\u2212Activity Relationship (SAR) Studies","volume":"60","author":"Spinelli","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026102305085830500_cit24","doi-asserted-by":"publisher","first-page":"114934","DOI":"10.1016\/j.biopha.2023.114934","article-title":"Pharmacological Insights Emerging from the Characterization of a Large Collection of Synthetic Cannabinoid Receptor Agonists Designer Drugs","volume":"164","author":"Gioe\u0301-Gallo","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"2026102305085830500_cit25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1039\/C8MD00595H","article-title":"Selective Modulation of the Cannabinoid Type 1 (CB1) Receptor as an Emerging Platform for the Treatment of Neuropathic Pain","volume":"10","author":"Banister","year":"2019","journal-title":"MedChemComm"},{"issue":"2","key":"2026102305085830500_cit26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/sj.bjp.0707568","article-title":"In Vitro and in Vivo Characterization of A-796260: A Selective Cannabinoid CB2 Receptor Agonist Exhibiting Analgesic Activity in Rodent Pain Models","volume":"153","author":"Yao","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"2026102305085830500_cit27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 Receptors: A Therapeutic Target for the Treatment of Inflammatory and Neuropathic Pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"19","key":"2026102305085830500_cit28","doi-asserted-by":"publisher","first-page":"11303","DOI":"10.1021\/acs.jmedchem.0c01567","article-title":"Correction to Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-Oxopyrazolo[4,3- b ]Pyridine-6-Carboxamide Derivatives with Antiosteoarthritic Activity In Vivo","volume":"63","author":"Mugnaini","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026102305085830500_cit29","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00705-021-05223-7","article-title":"Functional Variation (Q63R) in the Cannabinoid CB2 Receptor May Affect the Severity of COVID-19: A Human Study and Molecular Docking","volume":"166","author":"Rastegar","year":"2021","journal-title":"Arch. Virol."},{"issue":"3","key":"2026102305085830500_cit30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/v16030450","article-title":"Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal","volume":"16","author":"Samarelli","year":"2024","journal-title":"Viruses"},{"issue":"8","key":"2026102305085830500_cit31","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"de. Prevention of Alzheimer\u2019s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation","volume":"25","author":"Rami\u0301rez","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"2026102305085830500_cit32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms22010019","article-title":"CB2 Receptor in Microglia: The Guardian of Self-Control","volume":"22","author":"Komorowska-Mu\u0308ller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"2026102305085830500_cit33","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41401-020-0385-7","article-title":"Potential Application of Endocannabinoid System Agents in Neuropsychiatric and Neurodegenerative Diseases\ue5f8Focusing on FAAH\/MAGL Inhibitors","volume":"41","author":"Ren","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"2026102305085830500_cit34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/187152710793361568","article-title":"Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders","volume":"9","author":"Bisogno","year":"2010","journal-title":"CNS Neurol. Disord.\ue5f8Drug Targets-CNS Neurol. Disord."},{"key":"2026102305085830500_cit35","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41467-023-37112-9","article-title":"Structural Basis of Selective Cannabinoid CB2 Receptor Activation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"2026102305085830500_cit36","doi-asserted-by":"publisher","first-page":"108021","DOI":"10.1016\/j.phrs.2025.108021","article-title":"Kinetic Multiplex Assay to Assess Biased Signaling of Clinical GPCR Agonists","volume":"222","author":"Bouma","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"14","key":"2026102305085830500_cit37","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1111\/bph.15811","article-title":"Community Guidelines for GPCR Ligand Bias: IUPHAR Review 32","volume":"179","author":"Kolb","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"2026102305085830500_cit38","doi-asserted-by":"publisher","first-page":"1470016","DOI":"10.3389\/fimmu.2024.1470016","article-title":"Mast Cell MrgprB2 in Neuroimmune Interaction in IgE-Mediated Airway Inflammation and Its Modulation by \u03b2-Arrestin2","volume":"15","author":"Sutradhar","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"2026102305085830500_cit39","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/jcpe.13952","article-title":"Arrestin Beta-2 Deficiency Exacerbates Periodontal Inflammation by Mediating Activating Transcription Factor 6 Activation and Abnormal Remodelling of the Extracellular Matrix","volume":"51","author":"Feng","year":"2024","journal-title":"J. Clin. Periodontol."},{"key":"2026102305085830500_cit40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-Heteromer Mediated Regulation of Endocannabinoid Signaling in Activated Microglia. Role of CB1 and CB2 Receptors and Relevance for Alzheimer\u2019s Disease and Levodopa-Induced Dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"Brain, Behav., Immun."},{"issue":"5","key":"2026102305085830500_cit41","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1021\/acscentsci.3c01461","article-title":"Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists","volume":"10","author":"Kosar","year":"2024","journal-title":"ACS Cent. Sci."},{"issue":"4","key":"2026102305085830500_cit42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"issue":"3","key":"2026102305085830500_cit43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal Structure of the Human Cannabinoid Receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"1","key":"2026102305085830500_cit44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","article-title":"Generic GPCR Residue Numbers \u2212Aligning Topology Maps While Minding the Gaps","volume":"36","author":"Isberg","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"2026102305085830500_cit45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/17460441.2017.1365056","article-title":"Ligand Efficiency Metrics in Drug Discovery: The Pros and Cons from a Practical Perspective","volume":"12","author":"Cavalluzzi","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"22","key":"2026102305085830500_cit46","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1021\/acs.jcim.2c00852","article-title":"Estimation of Drug-Target Residence Time by Targeted Molecular Dynamics Simulations","volume":"62","author":"Ziada","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"2026102305085830500_cit47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/mol.117.108605","article-title":"A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies","volume":"92","author":"Martella","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"17","key":"2026102305085830500_cit48","doi-asserted-by":"publisher","first-page":"9527","DOI":"10.1021\/acs.analchem.7b02552","article-title":"Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System","volume":"89","author":"Cannaert","year":"2017","journal-title":"Anal. Chem."},{"key":"2026102305085830500_cit49","doi-asserted-by":"publisher","first-page":"112037","DOI":"10.1016\/j.ejmech.2020.112037","article-title":"Design and Synthesis of Fluorescent Ligands for the Detection of Cannabinoid Type 2 Receptor (CB2R)","volume":"188","author":"Spinelli","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026102305085830500_cit50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of Protein Using Bicinchoninic Acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"2026102305085830500_cit51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-0716-2728-0_15","article-title":"Cellular Assay to Study \u03b2-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2","volume-title":"Endocannabinoid Signaling: Methods and Protocols","author":"Bouma","year":"2023"},{"key":"2026102305085830500_cit52","doi-asserted-by":"publisher","first-page":"117680","DOI":"10.1016\/j.ejmech.2025.117680","article-title":"4,5-Diazafluorene Derivatives and Their Silver(I) Complexes: Synthesis and Biological Evaluation as Antiproliferative Agents","volume":"292","author":"Sandin-Mazzondo","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026102305085830500_cit53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0026-895X(25)15016-5","article-title":"The Kinetics of Competitive Radioligand Binding Predicted by the Law of Mass Action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"2026102305085830500_cit54","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug\u2212Target Residence Time and Its Implications for Lead Optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"2026102305085830500_cit55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A Simple Method for Quantifying Functional Selectivity and Agonist Bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"1219","key":"2026102305085830500_cit56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational Models of Pharmacological Agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"2026102305085830500_cit57","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.nlm.2018.02.014","article-title":"Topographical Memory Analyzed in Mice Using the Hamlet Test, a Novel Complex Maze","volume":"149","author":"Crouzier","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"issue":"7","key":"2026102305085830500_cit58","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"2026102305085830500_cit59","volume-title":"Schro\u0308dinger Release 2024-1","year":"2024"},{"key":"2026102305085830500_cit60","volume-title":"Protein Preparation Wizard","year":"2021"},{"issue":"7","key":"2026102305085830500_cit61","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"D1","key":"2026102305085830500_cit62","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM Database and PPM Web Server: Resources for Positioning of Proteins in Membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"27","key":"2026102305085830500_cit63","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward Realistic Biological Membrane Simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J. Comput. Chem."},{"key":"2026102305085830500_cit64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers","volume":"1\u22122","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"12","key":"2026102305085830500_cit65","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle Mesh Ewald: An N\u00b7log(N) Method for Ewald Sums in Large Systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"10","key":"2026102305085830500_cit66","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: A Toolkit for the Analysis of Molecular Dynamics Simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"2026102305085830500_cit67","doi-asserted-by":"publisher","first-page":"98","DOI":"10.25080\/Majora-629e541a-00e","article-title":"MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations","author":"Gowers","year":"2016","journal-title":"SciPy 2016"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c02401","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24727\/68777603\/jm6c02401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24727\/68777603\/jm6c02401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:21:46Z","timestamp":1792747306000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/24727\/5446502\/Design-and-Development-of-New-Dual-Target-Agents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":67,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c02401","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}